StoneX Group’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

StoneX Group’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-90,598	Closed	-$930K	–	509
2023 Q2	$930K	Buy	+90,598	New	+$925K	0.52%	40

StoneX Group's DALS Position: Q3 2023 in Review

StoneX Group sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 90,598 shares — an estimated $930K sold.

StoneX Group first reported a position in DALS in Q2 2023 and held it in 1 quarter. The position peaked at $930K in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

StoneX Group reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
StoneX Group sold 90,598 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $930K.
StoneX Group first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q2 2023 and held it in 1 quarter.
StoneX Group's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $930K in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on StoneX Group's 13F filing for Q3 2023, filed 15 Nov 2023.